The financial ramifications are just one angle patients — and providers — must consider when deciding to use healthcare AI. Others include how well the technology works among a diverse patient population and whether it can improve disease survival rates, according to the April 8 story.
“There’s a need for more diverse training and testing of these AI tools and algorithms in order to develop them across different races and different ethnicities,” Katerina Dodelzon, MD, a breast imaging radiologist at New York City-based NewYork-Presbyterian, told the newspaper. “AI is just a tool that learns based on what it sees.”
Some of the approximately two dozen AI mammography tools approved by the FDA are either being tested by hospitals or offered at a small number of clinics, The Times reported.
Health systems that aren’t charging patients for the added price tag of AI mammograms might be absorbing the costs themselves or using the tools strictly for research purposes at this point, according to the story.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.